Transcriptomics Technologies

Transcriptomics Technologies

Global Transcriptomics Technologies Market to Reach $10.9 Billion by 2027

Amid the COVID-19 crisis, the global market for Transcriptomics Technologies estimated at US$4.6 Billion in the year 2020, is projected to reach a revised size of US$10.9 Billion by 2027, growing at a CAGR of 13.1% over the analysis period 2020-2027. Microarray, one of the segments analyzed in the report, is projected to record a 11.2% CAGR and reach US$2.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Polymerase chain reaction (PCR) segment is readjusted to a revised 14.6% CAGR for the next 7-year period.

The U.S. Market is Estimated at $1.4 Billion, While China is Forecast to Grow at 12.7% CAGR

The Transcriptomics Technologies market in the U.S. is estimated at US$1.4 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.9 Billion by the year 2027 trailing a CAGR of 12.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 11.6% and 11.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 9.6% CAGR.

Sequencing Technologies Segment to Record 13% CAGR

In the global Sequencing Technologies segment, USA, Canada, Japan, China and Europe will drive the 12.8% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$776.9 Million in the year 2020 will reach a projected size of US$1.8 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$1.3 Billion by the year 2027.We bring years of research experience to this 7th edition of our report. The 231-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • Affymetrix, Inc.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche AG
  • Fluidigm Corporation
  • GE Healthcare
  • Illumina, Inc.
  • MilliporeSigma
  • Qiagen NV
  • Thermo Fisher Scientific, Inc.


Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. INTRODUCTION, METHODOLOGY & REPORT SCOPE
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Global Competitor Market Shares
Transcriptomics Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: Transcriptomics Technologies Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
TABLE 2: Transcriptomics Technologies Global Retrospective Market Scenario in US$ Million by Region/Country: 2012-2019
TABLE 3: Transcriptomics Technologies Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027
TABLE 4: Microarray (Technology) World Market by Region/Country in US$ Million: 2020 to 2027
TABLE 5: Microarray (Technology) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019
TABLE 6: Microarray (Technology) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027
TABLE 7: Polymerase chain reaction (PCR) (Technology) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027
TABLE 8: Polymerase chain reaction (PCR) (Technology) Historic Market Perspective by Region/Country in US$ Million: 2012 to 2019
TABLE 9: Polymerase chain reaction (PCR) (Technology) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027
TABLE 10: Sequencing Technologies (Technology) Geographic Market Spread Worldwide in US$ Million: 2020 to 2027
TABLE 11: Sequencing Technologies (Technology) Region Wise Breakdown of Global Historic Demand in US$ Million: 2012 to 2019
TABLE 12: Sequencing Technologies (Technology) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
TABLE 13: Other Technologies (Technology) World Market Estimates and Forecasts by Region/Country in US$ Million: 2020 to 2027
TABLE 14: Other Technologies (Technology) Market Historic Review by Region/Country in US$ Million: 2012 to 2019
TABLE 15: Other Technologies (Technology) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027
TABLE 16: Consumables (Product Segment) World Market by Region/Country in US$ Million: 2020 to 2027
TABLE 17: Consumables (Product Segment) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019
TABLE 18: Consumables (Product Segment) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
TABLE 19: Instruments (Product Segment) World Market Estimates and Forecasts in US$ Million by Region/Country: 2020 to 2027
TABLE 20: Instruments (Product Segment) Market Worldwide Historic Review by Region/Country in US$ Million: 2012 to 2019
TABLE 21: Instruments (Product Segment) Market Percentage Share Distribution by Region/Country: 2012 VS 2020 VS 2027
TABLE 22: Software (Product Segment) Market Opportunity Analysis Worldwide in US$ Million by Region/Country: 2020 to 2027
TABLE 23: Software (Product Segment) Global Historic Demand in US$ Million by Region/Country: 2012 to 2019
TABLE 24: Software (Product Segment) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
TABLE 25: Services (Product Segment) World Market by Region/Country in US$ Million: 2020 to 2027
TABLE 26: Services (Product Segment) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019
TABLE 27: Services (Product Segment) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027
TABLE 28: Pharmaceutical and biotechnology Companies (End-Use) Global Market Estimates & Forecasts in US$ Million by Region/Country: 2020-2027
TABLE 29: Pharmaceutical and biotechnology Companies (End-Use) Retrospective Demand Analysis in US$ Million by Region/Country: 2012-2019
TABLE 30: Pharmaceutical and biotechnology Companies (End-Use) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027
TABLE 31: Academic Research and Government Institutes (End-Use) Demand Potential Worldwide in US$ Million by Region/Country: 2020-2027
TABLE 32: Academic Research and Government Institutes (End-Use) Historic Sales Analysis in US$ Million by Region/Country: 2012-2019
TABLE 33: Academic Research and Government Institutes (End-Use) Share Breakdown Review by Region/Country: 2012 VS 2020 VS 2027
TABLE 34: Other End-Uses (End-Use) Worldwide Latent Demand Forecasts in US$ Million by Region/Country: 2020-2027
TABLE 35: Other End-Uses (End-Use) Global Historic Analysis in US$ Million by Region/Country: 2012-2019
TABLE 36: Other End-Uses (End-Use) Distribution of Global Sales by Region/Country: 2012 VS 2020 VS 2027
III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Transcriptomics Market Share (in %) by Company: 2019 & 2025
Market Analytics
TABLE 37: Transcriptomics Technologies Market in US$ Million in the United States by Technology: 2020-2027
TABLE 38: United States Transcriptomics Technologies Market Retrospective Analysis in US$ Million by Technology: 2012-2019
TABLE 39: United States Transcriptomics Technologies Market Share Breakdown by Technology: 2012 VS 2020 VS 2027
TABLE 40: United States Transcriptomics Technologies Market Estimates and Projections in US$ Million by Product Segment: 2020 to 2027
TABLE 41: Transcriptomics Technologies Market in the United States by Product Segment: A Historic Review in US$ Million for 2012-2019
TABLE 42: United States Transcriptomics Technologies Market Share Breakdown by Product Segment: 2012 VS 2020 VS 2027
TABLE 43: United States Transcriptomics Technologies Latent Demand Forecasts in US$ Million by End-Use: 2020 to 2027
TABLE 44: Transcriptomics Technologies Historic Demand Patterns in the United States by End-Use in US$ Million for 2012-2019
TABLE 45: Transcriptomics Technologies Market Share Breakdown in the United States by End-Use: 2012 VS 2020 VS 2027
CANADA
TABLE 46: Transcriptomics Technologies Market Analysis in Canada in US$ Million by Technology: 2020-2027
TABLE 47: Transcriptomics Technologies Market in Canada: Historic Review in US$ Million by Technology for the Period 2012-2019
TABLE 48: Canadian Transcriptomics Technologies Market Share Breakdown by Technology: 2012 VS 2020 VS 2027
TABLE 49: Canadian Transcriptomics Technologies Market Estimates and Forecasts in US$ Million by Product Segment: 2020 to 2027
TABLE 50: Canadian Transcriptomics Technologies Historic Market Review by Product Segment in US$ Million: 2012-2019
TABLE 51: Transcriptomics Technologies Market in Canada: Percentage Share Breakdown of Sales by Product Segment for 2012, 2020, and 2027
TABLE 52: Canadian Transcriptomics Technologies Market Quantitative Demand Analysis in US$ Million by End-Use: 2020 to 2027
TABLE 53: Transcriptomics Technologies Market in Canada: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2012-2019
TABLE 54: Canadian Transcriptomics Technologies Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
JAPAN
TABLE 55: Japanese Medium & Long-Term Outlook for Transcriptomics Technologies Market in US$ Million by Technology: 2020-2027
TABLE 56: Transcriptomics Technologies Market in Japan in US$ Million by Technology: 2012-2019
TABLE 57: Japanese Transcriptomics Technologies Market Percentage Share Distribution by Technology: 2012 VS 2020 VS 2027
TABLE 58: Japanese Market for Transcriptomics Technologies: Annual Sales Estimates and Projections in US$ Million by Product Segment for the Period 2020-2027
TABLE 59: Transcriptomics Technologies Market in Japan: Historic Sales Analysis in US$ Million by Product Segment for the Period 2012-2019
TABLE 60: Japanese Transcriptomics Technologies Market Share Analysis by Product Segment: 2012 VS 2020 VS 2027
TABLE 61: Japanese Demand Estimates and Forecasts for Transcriptomics Technologies in US$ Million by End-Use: 2020 to 2027
TABLE 62: Japanese Transcriptomics Technologies Market in US$ Million by End-Use: 2012-2019
TABLE 63: Transcriptomics Technologies Market Share Shift in Japan by End-Use: 2012 VS 2020 VS 2027
CHINA
TABLE 64: Transcriptomics Technologies Market Estimates and Forecasts in China in US$ Million by Technology: 2020-2027
TABLE 65: Chinese Transcriptomics Technologies Retrospective Market Scenario in US$ Million by Technology: 2012-2019
TABLE 66: Transcriptomics Technologies Market in China: Percentage Share Analysis by Technology for 2012, 2020, and 2027
TABLE 67: Chinese Transcriptomics Technologies Market Growth Prospects in US$ Million by Product Segment for the Period 2020-2027
TABLE 68: Transcriptomics Technologies Historic Market Analysis in China in US$ Million by Product Segment: 2012-2019
TABLE 69: Chinese Transcriptomics Technologies Market by Product Segment: Percentage Breakdown of Sales for 2012, 2020, and 2027
TABLE 70: Chinese Demand for Transcriptomics Technologies in US$ Million by End-Use: 2020 to 2027
TABLE 71: Transcriptomics Technologies Market Review in China in US$ Million by End-Use: 2012-2019
TABLE 72: Chinese Transcriptomics Technologies Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027
EUROPE
Market Facts & Figures
European Transcriptomics Market: Competitor Market Share Scenario (in %) for 2019 & 2025
Market Analytics
TABLE 73: European Transcriptomics Technologies Market Demand Scenario in US$ Million by Region/Country: 2020-2027
TABLE 74: Transcriptomics Technologies Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2012-2019
TABLE 75: European Transcriptomics Technologies Market Share Shift by Region/Country: 2012 VS 2020 VS 2027
TABLE 76: European Transcriptomics Technologies Market Assessment in US$ Million by Technology: 2020-2027
TABLE 77: European Transcriptomics Technologies Historic Market Review in US$ Million by Technology: 2012-2019
TABLE 78: Transcriptomics Technologies Market in Europe: Percentage Breakdown of Sales by Technology for 2012, 2020, and 2027
TABLE 79: European Transcriptomics Technologies Market Estimates and Forecasts in US$ Million by Product Segment: 2020-2027
TABLE 80: Transcriptomics Technologies Market in Europe in US$ Million by Product Segment: A Historic Review for the Period 2012-2019
TABLE 81: European Transcriptomics Technologies Market Share Breakdown by Product Segment: 2012 VS 2020 VS 2027
TABLE 82: European Transcriptomics Technologies Addressable Market Opportunity in US$ Million by End-Use: 2020-2027
TABLE 83: Transcriptomics Technologies Market in Europe: Summarization of Historic Demand in US$ Million by End-Use for the Period 2012-2019
TABLE 84: European Transcriptomics Technologies Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
FRANCE
TABLE 85: French Transcriptomics Technologies Market Estimates and Projections in US$ Million by Technology: 2020-2027
TABLE 86: French Transcriptomics Technologies Historic Market Analysis in US$ Million by Technology: 2012-2019
TABLE 87: French Transcriptomics Technologies Market Share Breakdown by Technology: 2012 VS 2020 VS 2027
TABLE 88: Transcriptomics Technologies Market in France by Product Segment: Estimates and Projections in US$ Million for the Period 2020-2027
TABLE 89: French Transcriptomics Technologies Historic Market Scenario in US$ Million by Product Segment: 2012-2019
TABLE 90: French Transcriptomics Technologies Market Share Analysis by Product Segment: 2012 VS 2020 VS 2027
TABLE 91: Transcriptomics Technologies Quantitative Demand Analysis in France in US$ Million by End-Use: 2020-2027
TABLE 92: French Transcriptomics Technologies Historic Market Review in US$ Million by End-Use: 2012-2019
TABLE 93: French Transcriptomics Technologies Market Share Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and 2027
GERMANY
TABLE 94: German Transcriptomics Technologies Latent Demand Forecasts in US$ Million by Technology: 2020-2027
TABLE 95: Transcriptomics Technologies Market in Germany: A Historic Perspective by Technology in US$ Million for the Period 2012-2019
TABLE 96: German Transcriptomics Technologies Market Share Breakdown by Technology: 2012 VS 2020 VS 2027
TABLE 97: Transcriptomics Technologies Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Product Segment for the Period 2020-2027
TABLE 98: German Transcriptomics Technologies Historic Market Analysis in US$ Million by Product Segment: 2012-2019
TABLE 99: German Transcriptomics Technologies Market Share Breakdown by Product Segment: 2012 VS 2020 VS 2027
TABLE 100: Transcriptomics Technologies Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2020-2027
TABLE 101: German Transcriptomics Technologies Market in Retrospect in US$ Million by End-Use: 2012-2019
TABLE 102: Transcriptomics Technologies Market Share Distribution in Germany by End-Use: 2012 VS 2020 VS 2027
ITALY
TABLE 103: Transcriptomics Technologies Market Estimates and Forecasts in Italy in US$ Million by Technology: 2020-2027
TABLE 104: Italian Transcriptomics Technologies Retrospective Market Scenario in US$ Million by Technology: 2012-2019
TABLE 105: Transcriptomics Technologies Market in Italy: Percentage Share Analysis by Technology for 2012, 2020, and 2027
TABLE 106: Italian Transcriptomics Technologies Market Growth Prospects in US$ Million by Product Segment for the Period 2020-2027
TABLE 107: Transcriptomics Technologies Historic Market Analysis in Italy in US$ Million by Product Segment: 2012-2019
TABLE 108: Italian Transcriptomics Technologies Market by Product Segment: Percentage Breakdown of Sales for 2012, 2020, and 2027
TABLE 109: Italian Demand for Transcriptomics Technologies in US$ Million by End-Use: 2020 to 2027
TABLE 110: Transcriptomics Technologies Market Review in Italy in US$ Million by End-Use: 2012-2019
TABLE 111: Italian Transcriptomics Technologies Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027
UNITED KINGDOM
TABLE 112: United Kingdom Medium & Long-Term Outlook for Transcriptomics Technologies Market in US$ Million by Technology: 2020-2027
TABLE 113: Transcriptomics Technologies Market in the United Kingdom in US$ Million by Technology: 2012-2019
TABLE 114: United Kingdom Transcriptomics Technologies Market Percentage Share Distribution by Technology: 2012 VS 2020 VS 2027
TABLE 115: United Kingdom Market for Transcriptomics Technologies: Annual Sales Estimates and Projections in US$ Million by Product Segment for the Period 2020-2027
TABLE 116: Transcriptomics Technologies Market in the United Kingdom: Historic Sales Analysis in US$ Million by Product Segment for the Period 2012-2019
TABLE 117: United Kingdom Transcriptomics Technologies Market Share Analysis by Product Segment: 2012 VS 2020 VS 2027
TABLE 118: United Kingdom Demand Estimates and Forecasts for Transcriptomics Technologies in US$ Million by End-Use: 2020 to 2027
TABLE 119: United Kingdom Transcriptomics Technologies Market in US$ Million by End-Use: 2012-2019
TABLE 120: Transcriptomics Technologies Market Share Shift in the United Kingdom by End-Use: 2012 VS 2020 VS 2027
REST OF EUROPE
TABLE 121: Rest of Europe Transcriptomics Technologies Market Assessment in US$ Million by Technology: 2020-2027
TABLE 122: Rest of Europe Transcriptomics Technologies Historic Market Review in US$ Million by Technology: 2012-2019
TABLE 123: Transcriptomics Technologies Market in Rest of Europe: Percentage Breakdown of Sales by Technology for 2012, 2020, and 2027
TABLE 124: Rest of Europe Transcriptomics Technologies Market Estimates and Forecasts in US$ Million by Product Segment: 2020-2027
TABLE 125: Transcriptomics Technologies Market in Rest of Europe in US$ Million by Product Segment: A Historic Review for the Period 2012-2019
TABLE 126: Rest of Europe Transcriptomics Technologies Market Share Breakdown by Product Segment: 2012 VS 2020 VS 2027
TABLE 127: Rest of Europe Transcriptomics Technologies Addressable Market Opportunity in US$ Million by End-Use: 2020-2027
TABLE 128: Transcriptomics Technologies Market in Rest of Europe: Summarization of Historic Demand in US$ Million by End-Use for the Period 2012-2019
TABLE 129: Rest of Europe Transcriptomics Technologies Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
ASIA-PACIFIC
TABLE 130: Asia-Pacific Transcriptomics Technologies Market Estimates and Projections in US$ Million by Technology: 2020-2027
TABLE 131: Asia-Pacific Transcriptomics Technologies Historic Market Analysis in US$ Million by Technology: 2012-2019
TABLE 132: Asia-Pacific Transcriptomics Technologies Historic Market Analysis in US$ Million by Technology: 2012 VS 2020 VS 2027
TABLE 133: Transcriptomics Technologies Market in Asia-Pacific by Product Segment: Estimates and Projections in US$ Million for the Period 2020-2027
TABLE 134: Asia-Pacific Transcriptomics Technologies Historic Market Scenario in US$ Million by Product Segment: 2012-2019
TABLE 135: Asia-Pacific Transcriptomics Technologies Market Share Analysis by Product Segment: 2012 VS 2020 VS 2027
TABLE 136: Transcriptomics Technologies Quantitative Demand Analysis in Asia-Pacific in US$ Million by End-Use: 2020-2027
TABLE 137: Asia-Pacific Transcriptomics Technologies Historic Market Review in US$ Million by End-Use: 2012-2019
TABLE 138: Asia-Pacific Transcriptomics Technologies Market Share Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and 2027
REST OF WORLD
TABLE 139: Transcriptomics Technologies Market Analysis in Rest of World in US$ Million by Technology: 2020-2027
TABLE 140: Transcriptomics Technologies Market in Rest of World: Historic Review in US$ Million by Technology for the Period 2012-2019
TABLE 141: Rest of World Transcriptomics Technologies Market Share Breakdown by Technology: 2012 VS 2020 VS 2027
TABLE 142: Rest of World Transcriptomics Technologies Market Estimates and Forecasts in US$ Million by Product Segment: 2020 to 2027
TABLE 143: Rest of World Transcriptomics Technologies Historic Market Review by Product Segment in US$ Million: 2012-2019
TABLE 144: Transcriptomics Technologies Market in Rest of World: Percentage Share Breakdown of Sales by Product Segment for 2012, 2020, and 2027
TABLE 145: Rest of World Transcriptomics Technologies Market Quantitative Demand Analysis in US$ Million by End-Use: 2020 to 2027
TABLE 146: Transcriptomics Technologies Market in Rest of World: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2012-2019
TABLE 147: Rest of World Transcriptomics Technologies Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
IV. COMPETITION
Total Companies Profiled: 42

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook